Lucas, C. M., Harris, R. J., Giannoudis, A., Davies, A., Knight, K., Watmough, S. J., Wang, L. and Clark, R. E. (2009) “Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript”, Haematologica. Pavia, Italy, 94(10), pp. 1362-1367. doi: 10.3324/haematol.2009.009134.